Defining substance use disorders: Dowe really need more than heavy use?

Alcohol and Alcoholism

Volumn 48, Issue 6, 2013, Pages 633-640

  Rehm, J ^a,b,c,d   Marmet, S ^e   Anderson, P ^f,g   Gual, A ^h   Kraus, L ^i,j   Nutt, D J ^k   Room, R ^j,l,m   Samokhvalov, A V ^b,d   Scafato, E ⁿ   Trapencieris, M ^o   Wiers, R W ^p   Gmel, G ^b,e,q,r  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e ADDICTION SWITZERLAND   (Switzerland)

^f NEWCASTLE UNIVERSITY   (United Kingdom)

^g MAASTRICHT UNIVERSITY   (Netherlands)

^h HOSPITAL CLÍNIC   (Spain)

ⁱ IFT INSTITUT FÜR THERAPIEFORSCHUNG   (Germany)

^j STOCKHOLM UNIVERSITY   (Sweden)

^k IMPERIAL COLLEGE LONDON   (United Kingdom)

^l UNIVERSITY OF MELBOURNE   (Australia)

^m TURNING POINT ALCOHOL AND DRUG CENTRE   (Australia)

ⁿ ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^o UNIVERSITY OF LATVIA   (Latvia)

^p UNIVERSITY OF AMSTERDAM   (Netherlands)

^q UNIVERSITY OF THE WEST OF ENGLAND   (United Kingdom)

^r LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

more..

Author keywords

[No Author keywords available]

Indexed keywords

PSYCHOTROPIC AGENT;

ARTICLE; DRUG USE; HUMAN; MORBIDITY; MORTALITY; PRIORITY JOURNAL; SOCIAL PROBLEM; SUBSTANCE ABUSE; TOBACCO DEPENDENCE; COMPLICATION; NOMENCLATURE; PSYCHOLOGY; SUBSTANCE-RELATED DISORDERS;

HUMANS; SUBSTANCE-RELATED DISORDERS; TERMINOLOGY AS TOPIC;

EID: 84886296998     PISSN: 07350414     EISSN: 14643502     Source Type: Journal    
DOI: 10.1093/alcalc/agt127     Document Type: Article

References (102)

1. Agerwala SM, McCance-Katz EF. (2012) Integrating screening, brief intervention, and referral to treatment (SBIRT) into clinical practice settings: a brief review. J Psychoactive Drugs 44:307-17.
2. American Psychiatric Association. (2000) Diagnostic and Statistical Manual of Mental Disorders (4th edition, text revision). Washington, DC: American Psychiatric Association.
3. American Psychiatric Association. (2013) Substance Use and Addiction-Related Disorders. Philadelphia: American Psychiatric Association.
4. Babor T, Higgins-Biddle J, Saunders 4th edition, text revisionJ et al. (2001) AUDIT-The Alcohol Use Disorders Identification Test: Guidelines for use in primary care. Geneva: World Health Organization.
5. Borges G, Ye Y, Bond J et al. (2010) The dimensionality of alcohol use disorders and alcohol consumption in a cross-national perspective. Addiction 105:240-54.
6. Broome J. (2004) Weighing Lives. Oxford: Oxford University Press.
7. Bruun K. (1971) Finland: the non-medical approach. In Kiloh LG, Bell DS (eds). Alcoholism and Drug Dependence. 29th International Congress on Alcoholism and Drug Dependence. Australia: Butterworths, 545-59.
8. Bush K, Kivlahan DR, McDonell MB et al. (1998) The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Arch Intern Med 158:1789-95.
9. Caetano R, Cunradi C. (2002) Alcohol dependence: a public health perspective. Addiction 97:633-45.
10. Caetano R, Tam T, Greenfield T et al. (1997) DSM-IV alcohol dependence and drinking in the U.S. population: a risk analysis. Ann Epidemiol 7:542-9.
11. Corrao G, Bagnardi V, Zambon A et al. (2004) A meta-analysis of alcohol consumption and the risk of 15 diseases. Prev Med 38:613-9.
12. Dawson DA, Li TK, Grant BF. (2008) A prospective study of risk drinking: at risk for what? Drug Alcohol Depend 95:62-72.
13. Dawson DA, Smith SM, Saha TD et al. (2012) Comparative performance of the AUDIT-C in screening for DSM-IV and DSM-5 alcohol use disorders. Drug Alcohol Depend 126:384-8.
14. de Girolamo G, Polidori G, Morosini P et al. (2006) Prevalence of common mental disorders in Italy: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD). Soc Psychiatry Psychiatr Epidemiol 41:853-61.
15. DiFranza J, Ursprung WW, Lauzon B et al. (2010) A systematic review of the Diagnostic and Statistical Manual diagnostic criteria for nicotine dependence. Addict Behav 35:373-82.
16. Doll R, Bradford Hill A. (2004) The mortality of doctors in relation to their smoking habits: a preliminary report. Br Med J 328:1529-33.
17. Doran CM, Duszynski KM, Beilby JJ et al. (2006) Use of pharmacotherapies for the management of addictive behaviours in Australian clinical practice. Addict Behav 31:1947-58.
18. European Medicines Agency. (2010) Guideline on the Development of Medicinal Products for the Treatment of Alcohol Dependence. London, UK: European Medicines Agency.
19. Everitt BJ, Robbins TW. (2005) Neural systems of reinforcement for drug addiction: from actions to habits to compulsion. Nat Neurosci 8:1481-9.
20. Fischer B, Kendall P, Rehm J et al. (1997) Charting WHO-goals for licit and illicit drugs for the year 2000: are we 'on track'? Public Health 111:217-75.
21. Fischer B, Jeffries V, Hall W et al. (2011) Lower risk cannabis use guidelines for Canada (LRCUG): a narrative review of evidence and recommendations. Can J Public Health 102:324-7.
22. Fischer B, Nakamura N, Urbanoski K et al. (2012) Correlations between population levels of prescription opioid use and prescription-opioid-related substance use treatment admissions in the USA and Canada since 2001. Public Health 126:749-51.
23. Frances A. (2013) Saving Normal: An Insider's Revolt Against Out-Of-Control Psychiatric Diagnosis, DSM-5, Big Pharma, and the Medicalization of Ordinary Life. New York, USA: William Morrow.
24. Gmel G, Rehm J. (2003) Harmful alcohol use. Alcohol Res Health 27:52-62.
25. Gmel G, Rehm J, Room R et al. (2000) Dimensions of alcoholrelated social harm in survey research. J Subst Abuse 12:113-38.
26. Gmel G, Heeb J, Rehm J. (2001) Is the frequency of drinking an indicator of problem drinking? A psychometric analysis of a modified version of the alcohol use disorders identification test in Switzerland. Drug Alcohol Depend 64:151-63.
27. Gmel G, Kuendig H, Maffli E et al. (2012) Suchtmonitoring Schweiz/ Jahresbericht - Daten 2011 [Addiction monitoring in Switzerland: Annual data for 2011]. Bern, Switzerland: Bundesamt für Gesundheit.
28. Grant BF, Compton WM, Crowley TJ et al. (2007) Errors in assessing DSM-IV substance use disorders. Arch Gen Psychiatry 64:379-80.
29. Heatherton TF, Kozlowski LT, Frecker RC et al. (1991) The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. Br J Addict 86:1119-27.
30. Hendricks PS, Prochaska JJ, Humfleet GL et al. (2008) Evaluating the validities of different DSM-IV based conceptual constructs of tobacco dependence. Addiction 103:1215-23.
31. Holly A, Wittchen H-U. (1998) Patterns of use and their relationship to DSM-IV abuse and dependence of alcohol among adolescents and young adults. Eur Addict Res 4:50-7.
32. Hradilova Selin K. (2006) Alcohol Use Disorder Identification Test (AUDIT): What does it screen? Performance of the AUDIT against four different criteria in a Swedish population sample. Subst Use Misuse 41:1881-99.
33. Hser Y, Hoffman V, Grella C et al. (2001) A 33-year follow-up of narcotics addicts. Arch Gen Psychiatry 58:503-8.
34. Humeniuk R, Ali R, Babor T et al. (2012) A randomized controlled trial of a brief intervention for illicit drugs linked to the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) in clients recruited from primary health-care settings in four countries. Addiction 107:957-66.
35. John U, Meyer C, Rumpf HJ et al. (2009) Nicotine dependence criteria and nicotine withdrawal symptoms in relation to pain among an adult general population sample. Eur J Pain 13:82-8.
36. Kaner EF, Beyer F, Dickinson HO et al. (2007) Effectiveness of brief alcohol interventions in primary care populations. Cochrane Database Syst Rev 18:CD004148.
37. Kaplan RF, Cooney NL, Baker LH et al. (1985) Reactivity to alcoholrelated cues: physiological and subjective responses in alcoholics and nonproblem drinkers. J Stud Alcohol 46:034-272.
38. Kawakami N, Takatsuka N, Inaba S et al. (1999) Development of a screening questionnaire for tobacco/nicotine dependence according to ICD-10, DSM-III-r, and DSM-IV. Addict Behav 24:155-66.
39. Kehoe T, Gmel G, Jr, Shield K et al. (2012) Determining the best population-level alcohol consumption model and its impact on estimates of alcohol-attributable harms. Popul Health Metr 10:6.
40. Khuder SA. (2001) Effect of cigarette smoking on major histological types of lung cancer: a meta-analysis. Lung Cancer 31:139-48.
41. Kraus L, Baumeister SE. (2008) Studiendesign und Methodik des Epidemiologischen Suchtsurveys 2006 [Study design and methodology of the 2006 Epidemiological Survey of Substance Abuse]. Sucht 54:S6-S15.
42. Kraus L, Pabst A. (2010) Studiendesign und Methodik des Epidemiologischen Suchtsurveys 2009. SUCHT-Zeitschrift für Wissenschaft und Praxis/Journal of Addiction Research and Practice [Study design and methodology of the 2009 Epidemiological Survey of Substance Abuse] 56:315-26.
43. Laslett AM, Catalano P, Chikritzhs T et al. (2010) The Range and Magnitude of Alcohol's Harm to Others. Fitzroy, VIC: Turning Point Alcohol & Drug Centre.
44. Laslett AM, Room R, Ferris J et al. (2011) Surveying the range and magnitude of alcohol's harm to others in Australia. Addiction 106:1603-11.
45. Leshner AI. (1997) Addiction is a brain disease, and it matters. Science 278:45-7.
46. Lessov CN, Martin NG, Statham DJ et al. (2004) Defining nicotine dependence for genetic research: evidence from Australian twins. Psychol Med 34:865-79.
47. Li TK, Hewitt BG, Grant BF. (2007a) The alcohol dependence syndrome, 30 years later: a commentary. The 2006 H. David Archibald lecture. Addiction 102:1522-30.
48. Li TK, Hewitt BG, Grant BF. (2007b) Is there a future for quantifying drinking in the diagnosis, treatment, and prevention of alcohol use disorders? Alcohol Alcohol 41:57-63.
49. Lim SS, Vos T, Flaxman AD et al. (2012) A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380:2224-60.
50. Loukola A, Broms U, Maunu H et al. (2008) Linkage of nicotine dependence and smoking behavior on 10q, 7q and 11p in twins with homogeneous genetic background. Pharmaogenetics J 8:209-19.
51. Miller NS, Belkin BM, Gold MS. (1991) Alcohol and drug dependence among the elderly: epidemiology, diagnosis, and treatment. Compr Psychiatry 32:153-65.
52. Muthén B. (1984) A general structural equation model with dichotomous, ordered categorical, and continuous latent variable indicators. Psychometrika 49:115-32.
53. National Centre for Social Research and University of Leicester. (2011) Adult Psychiatric Morbidity Survey, 2007 [computer file], 3rd edn. Colchester, Essex: UK Data Archive.
54. National Health Medical Research Council. (2009) Australian Guidelines to Reduce Health Risks from Drinking Alcohol. Australia: Commonwealth of Australia.
55. Neuman MD, Bitton A, Glantz SA. (2005) Tobacco industry influence on the definition of tobacco related disorders by the American Psychiatric Association. Tob Control 14:328-37.
56. Nutt DJ, King LA, Phillips LD. Drugs. FtISCo. (2010) Drug harms in the UK: a multicriteria decision analysis. Lancet 376:1558-65.
57. Pabst A, Kraus L, Piontek D et al. (2012) Age differences in diagnostic criteria of DSM-IV alcohol dependence among adults with similar drinking behaviour. Addiction 107:331-8.
58. Park S, Lee JY, Song TM et al. (2012) Age-associated changes in nicotine dependence. Public Health 126:482-9.
59. Piontek D, Kraus L, Legleye S et al. (2011) The validity of DSM-IV cannabis abuse and dependence criteria in adolescents and the value of additional cannabis use indicators. Addiction 106:1137-45.
60. Popova S, Rehm J, Patra J et al. (2007) Comparing alcohol consumption in central and eastern Europe to other European countries. Alcohol Alcohol 42:465-73.
61. Popova S, Patra J, Rehm J. (2009) Avoidable portion of tobacco-attributable acute care hospital days and its cost due to implementation of different intervention strategies in Canada. Int J Environ Res Public Health 6:2179-92.
62. Rehm J, Roerecke M. (2013) Reduction of drinking in problem drinkers and aLl-cause mortality. Alcohol Alcohol 48:509-13.
63. Rehm J, Room R. (2009) Why do we need international regulations for alcohol control? Nordic Stud Alcohol Drugs 24:447-50.
64. Rehm J, Room R, Van den Brink W et al. (2005) Alcohol use disorders in EU countries and Norway: an overview of the epidemiology. Eur Neuropsychopharmacol 15:377-88.
65. Rehm J, Greenfield T, Kerr W. (2006) Patterns of drinking and mortality from different diseases-an overview. Contemp Drug Probl 33:205-35.
66. Rehm J, Gnam W, Popova S et al. (2007a) The costs of alcohol, illegal drugs, and tobacco in Canada, 2002. J Stud Alcohol Drugs 68:886-95.
67. Rehm J, Klotsche J, Patra J. (2007b) Comparative quantification of alcohol exposure as risk factor for global burden of disease. Int J Methods Psychiatr Res 16:66-76.
68. Rehm J, Sulkowska U, Manczuk M et al. (2007c) Alcohol accounts for a high proportion of premature mortality in central and eastern Europe. Int J Epidemiol 36:458-67.
69. Rehm J, Room R, Taylor B. (2008) Method for moderation: measuring lifetime risk of alcohol-attributable mortality as a basis for drinking guidelines. Int J Methods Psychiatr Res 17:141-51.
70. Rehm J, Baliunas D, Borges GLG et al. (2010a) The relation between different dimensions of alcohol consumption and burden of disease-an overview. Addiction 105:817-43.
71. Rehm J, Kehoe T, Gmel G et al. (2010b) Statistical modeling of volume of alcohol exposure for epidemiological studies of population health: the example of the US. Popul Health Metr 8:3.
72. Rehm J, Frick U, Fischer B. (2011a) Substanzgebrauchsstörungen- ein neuer Ansatz im DSM 5? [Substance-use disorders-a new approach in DSM 5?]. Sucht 57:54-5.
73. Rehm J, Zatonski W, Taylor B et al. (2011b) Epidemiology and alcohol policy in Europe. Addiction 106:11-9.
74. Rehm J, Shield KD, Rehm MX et al. (2012) Alcohol Consumption, Alcohol Dependence, and Attributable Burden of Disease in Europe: Potential Gains from Effective Interventions for Alcohol Dependence. Toronto, Canada: Centre for Addiction and Mental Health.
75. Rehm J, Shield KD, Rehm MX et al. (2013) Modelling the impact of alcohol dependence on mortality burden and the effect of available treatment interventions in the European Union. Eur Neuropsychopharmacol 23:89-97.
76. Robins LN. (1993) The sixth Thomas James Okey Memorial Lecture. Vietnam veterans' rapid recovery from heroin addiction: a fluke or normal expectation? Addiction 88:1041-54.
77. Roerecke M, Rehm J. (2013) Alcohol use disorders and mortality-a systematic review and meta-analysis. Addiction (epub ahead of print).
78. Room R. (1998) Alcohol and drug disorders in the International Classification of Diseases: a shifting kaleidoscope. Drug Alcohol Rev 17:305-17.
79. Room R. (2006) Taking account of cultural and societal influences on substance use diagnoses and criteria. Addiction 101: 31-9.
80. Room R. (2007) Understanding cultural differences in young people's drinking. In Järvinen M, Room R (eds). Youth Drinking Cultures: European Experiences. Vermont: Ashgate Publishing, 17-40.
81. Room R, Janca A, Bennett LA et al. (1996) WHO cross-cultural applicability research on diagnosis and assessment of substance use disorders: an overview of methods and selected results. Addiction 91:199-220.
82. Room R, Rehm J, Trotter RTI, (2001) Cross-cultural views on stigma, valuation, parity, and societal values towards disability. In Üstün TB, Chatterji S, Bickenbach JE et al. (eds). Disability and Culture: Universalism and Diversity. Seattle: Higrefe and Huber, 247-91.
83. Room R, Schmidt L, Rehm J et al. (2008) International regulation of alcohol. A framework convention is needed, as for tobacco control. Br Med J 337:a2364.
84. Saha TD, Chou SP, Grant BF. (2006) Toward an alcohol use disorder continuum using item response theory: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Psychol Med 36:931-41.
85. Saha TD, Stinson FS, Grant BF. (2007) The role of alcohol consumption in future classifications of alcohol use disorders. Drug Alcohol Depend 89:82-92.
86. Saha TD, Compton WM, Pulay AJ et al. (2010) Dimensionality of DSM-IV nicotine dependence in a national sample: an item response theory application. Drug Alcohol Depend 108:21-8.
87. Scafato E, Allamani A, Patussi V et al. (2005) Italy. In Heather N. (ed). WHO Collaborative project on Identification and Management of Alcohol-Related Problems in Primary Health Care-Report on Phase IV. Geneva, Switzerland: World Health Organization, 131-44.
88. Schomerus G, Lucht M, Holzinger A et al. (2011) The stigma of alcohol dependence compared with other mental disorders: a review of population studies. Alcohol Alcohol 46:105-12.
89. Schomerus G, Matschinger H, Angermeyer MC. (2013) Continuum beliefs and stigmatizing attitudes towards persons with schizophrenia, depression and alcohol dependence. Psychiatry Res (epub ahead of print).
90. Schuckit MA. (2009) Alcohol-use disorders. Lancet 373:492-501.
91. Shield KD, Kehoe T, Gmel G et al. (2012) Societal burden of alcohol. In Anderson P, Møller L, Galea G (eds). Alcohol in the European Union. Consumption, Harm and Policy Approaches. Copenhagen, Denmark: World Health Organization Regional Office for Europe, 10-28.
92. Shield K, Rylett M, Gmel Gs et al. (2013) Global alcohol exposure estimates by country, territory and region for 2005-a contribution to the Comparative Risk Assessment for the 2010 Global Burden of Disease Study. Addiction 108: 912-22.
93. Snikere S, Trapencieris M, Koroleva I et al. (2011) Atkari bu izraisoso vielu lietosana iedzi vota ju vidu 2011. Analitisks parskats. [Substance use among the population in 2011. Analytic report]. Riga: Slimibu profilakses un kontroles centrs.
94. Strong DR, Kahler CW, Ramsey SE et al. (2003) Finding order in the DSM-IV nicotine dependence syndrome: a Rasch analysis. Drug Alcohol Depend 72:151-62.
95. Volkow ND, Li TK. (2005) Drugs and alcohol: treating and preventing abuse, addiction and their medical consequences. Pharmacol Ther 108:3-17.
96. WHO ASSIST Working Group. (2002) The Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): development, reliability and feasibility. Addiction 97:1183-94.
97. Wiers RW, Cousijn J, Ter Mors-Schulte M et al. (2012) State of the art: neurocognitieve effecten van verslaving [Neurocognitive effects of addiction]. Den Haag, The Netherlands: ZonMw - Programma Risicogedrag en Afhankelijkheid.
98. Wittchen HU, Lachner G, Wunderlich U et al. (1998) Test-retest reliability of the computerized DSM-IV version of the Munich- Composite International Diagnostic Interview (M-CIDI). Soc Psychiatry Psychiatr Epidemiol 33:568-78.
99. Wood E, Werb D, Kazatchkine M et al. (2010) Vienna Declaration: a call for evidence-based drug policies. Lancet 376:310-2.
100. World Health Organization. (1957) WHO Expert Committee on Addiction-Producing Drugs, Seventh Report. Geneva, Switzerland: World Health Organization.
101. World Health Organization. (1992) ICD-10 Classification of Mental and Behavioural Disorder: Clinical Descriptions and Diagnostic Guidelines. Geneva, Switzerland: World Health Organization.
102. World Health Organization. (2011) Global Status Report on Alcohol and Health. Geneva, Switzerland: World Health Organization.